Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Daniel Prieto-Alhambra"'
Autor:
Albert Prats-Uribe, Daniel Prieto-Alhambra, Scott L. DuVall, Sergio Fernandez-Bertolin, Lisa M. Schilling, Osaid Alser, Dalia Dawoud, Elena Roel, Jose D. Posada, Paras P. Mehta, Carlos Areia, Vignesh Subbian, Andrea Pistillo, Karishma Shah, Jennifer C E Lane, Edward Burn, Martina Recalde, Thamir M. Alshammari, Kristin Kostka, Anthony G. Sena, Asieh Golozar, Christian G. Reich, Thomas Falconer, Waheed-Ul-Rahman Ahmed, Nigam H. Shah, Fredrik Nyberg, Paula Casajust, Talita Duarte-Salles, Kristine E. Lynch, Peter R. Rijnbeek, Karthik Natarjan, Lana Yin Hui Lai, Michael E. Matheny, Daniel R. Morales, Patrick B. Ryan, Hong Zhu, Mengchun Gong, Heba Alghoul, Lin Zhang
Publikováno v:
International Journal of Obesity
International Journal of Obesity (2005)
International Journal of Obesity, 45(11), 2347-2357. Nature Publishing Group
International Journal of Obesity (2005)
International Journal of Obesity, 45(11), 2347-2357. Nature Publishing Group
Background A detailed characterization of patients with COVID-19 living with obesity has not yet been undertaken. We aimed to describe and compare the demographics, medical conditions, and outcomes of COVID-19 patients living with obesity (PLWO) to t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba943a091db5d2e0692f481043d4ebfe
https://ora.ox.ac.uk/objects/uuid:370e4877-415f-4480-9c26-06f02a124843
https://ora.ox.ac.uk/objects/uuid:370e4877-415f-4480-9c26-06f02a124843
Autor:
A Diez-Perez, Didac Mauricio, Berta Soldevila, E Losada, Daniel Prieto-Alhambra, D Martinez-Laguna, M S Ali, Manel Puig-Domingo, Xavier Nogués
Publikováno v:
Osteoporosis International
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Summary We conducted a nested case–control study to study the association between antidiabetic treatments (alone or in combination) use and fracture risk among incident type 2 Diabetes mellitus patients. We found an increased risk of bone fracture
Autor:
Cristian Tebé, Victor Moreno, D Martinez-Laguna, Cyrus Cooper, Gary S. Collins, Daniel Prieto-Alhambra, Adolfo Diez-Perez
Publikováno v:
Journal of Bone and Mineral Research. 33:1417-1421
Type 2 diabetes (T2DM) is associated with a reduced life expectancy. The latest published evidence suggests an increased risk of fractures among T2DM patients. We conducted a population-based cohort study to determine the impact of mortality as a com
Autor:
Consuelo Huerta-Alvarez, Daniel Prieto-Alhambra, Arturo Álvarez-Gutiérrez, Elisa Martín-Merino, Dolores Montero-Corominas
Publikováno v:
Bone. 105:292-298
Objective Different regulatory actions for anti-osteoporosis medication (AOM) were taken during the last years, including marketing of new drugs, safety warnings, or restrictions on the indications. We aimed to characterise the secular trends of AOM
Autor:
Alessandro Pasqua, Iacopo Cricelli, Maria Luisa Brandi, Claudio Cricelli, Bruno Frediani, Elisa Bianchini, Daniel Prieto-Alhambra, Raffaella Michieli, Francesco Lapi, Giampiero Mazzaglia
Publikováno v:
Calcified Tissue International. 100:537-549
We aimed to develop and validate the FRActure Health Search (FRA-HS) score for prediction of risk of osteoporotic fractures in primary care in Italy. We selected a cohort of patients aged 40 years between 1999 and 2002. They were followed until the o
Autor:
Samuel Hawley, J Lippett, C. Cooper, Muhammad Javaid, Anjali Shah, Andrew Judge, Daniel Prieto-Alhambra, Antonella Delmestri
Publikováno v:
Shah, A, Prieto-Alhambra, D, Hawley, S, Delmestri, A, Lippett, J, Cooper, C, Judge, A & Javaid, M K 2017, ' Geographic variation in secondary fracture prevention after a hip fracture during 1999-2013 : a UK study ', Osteoporosis International, vol. 28, no. 1, pp. 169-178 . https://doi.org/10.1007/s00198-016-3811-4
Fragility fractures of the hip have a major impact on the lives of patients and their families. This study highlights significant geographical variation in secondary fracture prevention with even the highest performing regions failing the majority of
Autor:
Jose Leal, Daniel Prieto-Alhambra, Alastair Gray, Antonella Delmestri, Samuel Hawley, Cyrus Cooper, Muhammad Javaid, Andrew Judge, Nigel K Arden
Publikováno v:
Journal of Bone and Mineral Research. 32:203-211
Fracture liaison services are recommended as a model of best practice for organizing patient care and secondary fracture prevention for hip fracture patients, although variation exists in how such services are structured. There is considerable uncert
Publikováno v:
Osteoporosis International, 27(3), 849-852. Springer-Verlag London Ltd.
The concept that our patients need to interrupt or stop bisphosphonate therapy for osteoporosis after 5 years of oral bisphosphonate therapy and after 3 years of intravenous bisphosphonate therapy has gained considerable traction worldwide. It has be
Autor:
Muhammad Javaid, Daniel Prieto-Alhambra, Adolfo Diez-Perez, R. Eastell, Nigel K Arden, Katrine Hass Rubin, Cyrus Cooper, Samuel Hawley, Andrew Judge, Peter Vestergaard, Bo Abrahamsen
Publikováno v:
Journal of Bone and Mineral Research. 31:234-244
Oral bisphosphonates (BPs) are highly effective in preventing fractures and are recommended first-line therapies for patients with osteoporosis. We identified the incidence and predictors of oral BP treatment failure, defined as the incidence of two
Autor:
Daniel Prieto-Alhambra, Irene Petersen, Antonella Delmestri, Cyrus Cooper, T P van Staa, Samuel Hawley, Muhammad Javaid, Elisa Martín-Merino, S Khalid, Ana Llorente-García, Arturo Álvarez-Gutiérrez, Andrew Judge
Publikováno v:
Martín-Merino, E, Petersen, I, Hawley, S, Álvarez-Gutierrez, A, Khalid, S, Llorente-Garcia, A, Delmestri, A, Javaid, M K, Van Staa, T P, Judge, A, Cooper, C & Prieto-Alhambra, D 2018, ' Risk of venous thromboembolism among users of different anti-osteoporosis drugs : a population-based cohort analysis including over 200,000 participants from Spain and the UK ', Osteoporosis International, vol. 29, no. 2, pp. 467–478 . https://doi.org/10.1007/s00198-017-4308-5
Osteoporosis International, 29(2), 467. Springer London
Osteoporosis International, 29(2), 467. Springer London
Summary: The venous thromboembolism risk among anti-osteoporotics is unknown. In this primary care study, the risk with other bisphosphonates [1.05 (0.94–1.18) and 0.96 (0.78–1.18)], strontium [0.90 (0.61–1.34) and 1.19 (0.82–1.74)], in the U
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61ea1c66acd73521280d5a741fc8a6b8
https://research-information.bris.ac.uk/en/publications/96424aca-97f6-4f82-9a2c-17ac31191ef6
https://research-information.bris.ac.uk/en/publications/96424aca-97f6-4f82-9a2c-17ac31191ef6